Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,689 | 66 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $517.01 | 21 | $0 (2024) |
| Galderma Laboratories, L.P. | $255.47 | 5 | $0 (2024) |
| Allergan, Inc. | $246.26 | 7 | $0 (2022) |
| Novo Nordisk Inc | $119.33 | 6 | $0 (2024) |
| GENZYME CORPORATION | $93.52 | 3 | $0 (2024) |
| Alkermes, Inc. | $51.91 | 3 | $0 (2023) |
| Lilly USA, LLC | $40.48 | 2 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $33.19 | 2 | $0 (2022) |
| Bausch Health US, LLC | $30.93 | 2 | $0 (2022) |
| Esperion Therapeutics, Inc. | $28.64 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $595.07 | 23 | Galderma Laboratories, L.P. ($233.20) |
| 2023 | $448.56 | 15 | ABBVIE INC. ($293.46) |
| 2022 | $332.65 | 12 | Allergan, Inc. ($180.77) |
| 2021 | $312.73 | 16 | Allergan, Inc. ($65.49) |
All Payment Transactions
66 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $22.51 | General |
| 11/11/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/07/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $35.24 | General |
| 10/30/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $3.92 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/25/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.78 | General |
| Category: Immunology | ||||||
| 10/21/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $28.00 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 10/18/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $23.92 | General |
| Category: Obesity | ||||||
| 10/11/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $12.20 | General |
| 09/13/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $26.37 | General |
| Category: Neurology | ||||||
| 08/30/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/21/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $165.31 | General |
| 08/16/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $23.84 | General |
| Category: Diabetes | ||||||
| 08/15/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $24.01 | General |
| Category: FACIAL AESTHETICS | ||||||
| 07/30/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $8.50 | General |
| Category: FACIAL AESTHETICS | ||||||
| 06/21/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: NEUROSCIENCE | ||||||
| 06/20/2024 | Novo Nordisk Inc | Saxenda (Drug), Wegovy | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: Obesity | ||||||
| 06/08/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: NEUROSCIENCE | ||||||
| 05/23/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: FACIAL AESTHETICS | ||||||
| 03/15/2024 | Phadia US Inc. | ImmunoCAP (Device) | Food and Beverage | Cash or cash equivalent | $16.25 | General |
| Category: Allergy/Immunology | ||||||
| 02/29/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $7.91 | General |
| Category: FACIAL AESTHETICS | ||||||
| 02/21/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $20.45 | General |
| 02/20/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $5.09 | General |
| 02/06/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/26/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $1.94 | General |
| Category: FACIAL AESTHETICS | ||||||
| 09/29/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: General - Pain Management_NMD | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 196 | 262 | $31,931 | $13,560 |
| 2022 | 5 | 140 | 163 | $25,035 | $10,775 |
| 2021 | 5 | 133 | 149 | $22,410 | $10,690 |
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 72 | 76 | $13,300 | $5,484 | 41.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 51 | 63 | $8,210 | $3,908 | 47.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 19 | 21 | $2,750 | $1,588 | 57.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 24 | 24 | $3,360 | $1,550 | 46.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 19 | 21 | $3,570 | $756.62 | 21.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 11 | 57 | $741.00 | $272.29 | 36.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 57 | 64 | $11,235 | $4,860 | 43.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 31 | 38 | $4,940 | $2,255 | 45.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 22 | 25 | $3,500 | $1,641 | 46.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 16 | 19 | $2,470 | $1,397 | 56.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 14 | 17 | $2,890 | $621.77 | 21.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 43 | 48 | $8,400 | $4,191 | 49.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 39 | 45 | $5,850 | $2,745 | 46.9% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 25 | 28 | $3,920 | $2,097 | 53.5% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 13 | 13 | $1,690 | $1,089 | 64.5% |
| 17000 | Destruction of skin growth | Office | 2021 | 13 | 15 | $2,550 | $567.34 | 22.2% |
About Ivy Prothro, FNP-BC
Ivy Prothro, FNP-BC is a Family healthcare provider based in Bethesda, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/12/2020. The National Provider Identifier (NPI) number assigned to this provider is 1811529381.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ivy Prothro, FNP-BC has received a total of $1,689 in payments from pharmaceutical and medical device companies, with $595.07 received in 2024. These payments were reported across 66 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($1,689).
As a Medicare-enrolled provider, Prothro has provided services to 469 Medicare beneficiaries, totaling 574 services with total Medicare billing of $35,025. Data is available for 3 years (2021–2023), covering 16 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Bethesda, MD
- Active Since 02/12/2020
- Last Updated 02/12/2020
- Taxonomy Code 363LF0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1811529381
Products in Payments
- BOTOX (Biological) $367.19
- DUPIXENT (Biological) $93.52
- UBRELVY (Drug) $47.76
- Saxenda (Drug) $44.73
- QULIPTA (Drug) $42.82
- Ozempic (Drug) $41.26
- TRINTELLIX (Drug) $33.19
- VIVITROL (Drug) $32.09
- APLENZIN (Drug) $30.93
- NEXLETOL (Drug) $28.64
- DAXXIFY (Drug) $28.00
- Sunosi (Drug) $26.37
- ZEPBOUND (Drug) $23.92
- AJOVY (Biological) $23.75
- FARXIGA (Drug) $21.65
- Vivitrol (Drug) $19.82
- Xofluza (Drug) $19.34
- VOQUEZNA (Drug) $18.84
- Rybelsus (Drug) $17.44
- Cologuard Collection Kit (Device) $17.17
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Bethesda
Diana Rapalo, Crnp, CRNP
Family — Payments: $7,903
Dr. Rita Meadows, Phd, Fnp-Bc, PHD, FNP-BC
Family — Payments: $7,865
Elizabeth Smith, Np, NP
Family — Payments: $5,800
Nichola Nelson
Family — Payments: $4,478
Deirdre Angelastro, Fnp, FNP
Family — Payments: $2,810
Katharine Vincent
Family — Payments: $2,574